Sean N Tucker, PhD

home / authors / sean-n-tucker-phd

Chief Security Officer and VP of Research at Vaxart.

Articles

Vaxart's Oral Norovirus Vaccine: Key Study Findings and Future Plans

Vaxart's Oral Norovirus Vaccine: Key Study Findings and Future Plans

Sophia Abene;Sean N Tucker, PhD
March 6th 2025

Sean Tucker, PhD, highlights effective immune response and mucosal immunity, paving the way for broader applications in viral disease prevention.

Read More

Oral Norovirus Gastroenteritis Vaccine VXA-GI.1-NN Shows Efficacy

Oral Norovirus Gastroenteritis Vaccine VXA-GI.1-NN Shows Efficacy

Sophia Abene;Sean N Tucker, PhD
October 18th 2024

Sean N Tucker, PhD, highlighted that VXA-GI.1-NN demonstrated safety and efficacy in reducing norovirus infections, marking a potential treatment in prevention for a diverse range of demographics.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
How a Prodrug Approach May Aid In Antimalarial Development
Published: March 21st 2025 | Updated: March 25th 2025
How a Prodrug Approach May Aid In Antimalarial Development
Large Hospital System Experiences Significant Increases in Candida auris
Published: March 21st 2025 | Updated: March 25th 2025
Large Hospital System Experiences Significant Increases in Candida auris
Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial
Published: March 17th 2025 | Updated: March 25th 2025
Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial
HIV Prevention: Discussing PrEP, PEP, and Vaccine Development
Published: March 13th 2025 | Updated: March 25th 2025
HIV Prevention: Discussing PrEP, PEP, and Vaccine Development
The Business Sector's Advocacy to Maintain Funding for HIV Prevention, Research, Treatment
Published: March 14th 2025 | Updated: March 25th 2025
The Business Sector's Advocacy to Maintain Funding for HIV Prevention, Research, Treatment
© 2025 MJH Life Sciences

All rights reserved.